HomeInvestors HealthEli Lilly, Novo stocks in focus as RFK Jr. leads HHS (NVO:NYSE) Eli Lilly, Novo stocks in focus as RFK Jr. leads HHS (NVO:NYSE) By BOMAR ENT. February 16, 2025 FacebookTwitterPinterestWhatsApp Andrew Harnik/Getty Images News Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) have found themselves in two contrasting positions as Robert F. Kennedy Jr., a leading critic of weight loss drugs, takes the helm of the Department of Health Source link Previous articleAre Our Predictions Already Wrong?Next articleTHE PATH TO SUCCESS IN TRADING latest articles explore more Cryptocurrency Investing for Beginners: Unlock Digital Wealth with Bitcoin, Ethereum, Altcoins, and Defi Hands-On Smart Contract Development with Solidity and Ethereum: From Fundamentals to Deployment The White-Collar Recession Means More for Real Estate Than You Think Eliminating Property Taxes: What Homeowners Gain and Give Up How to Achieve 5% Monthly Returns Trading Stocks: A Practical Guide for Consistent Growth The Dividend ETF Retirement Blueprint LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
